Cargando…
Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality
Given the continued spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), early predictors of coronavirus disease 19 (COVID-19) mortality might improve patients’ outcomes. Increased levels of circulating neurofilament light chain (NfL), a biomarker of neuro-axonal injury, have been...
Autores principales: | Masvekar, Ruturaj R., Kosa, Peter, Jin, Kimberly, Dobbs, Kerry, Stack, Michael A., Castagnoli, Riccardo, Quaresima, Virginia, Su, Helen C., Imberti, Luisa, Notarangelo, Luigi D., Bielekova, Bibiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786234/ https://www.ncbi.nlm.nih.gov/pubmed/35075461 http://dx.doi.org/10.1101/2022.01.13.22269244 |
Ejemplares similares
-
Prognostic value of serum/plasma neurofilament light chain for COVID‐19‐associated mortality
por: Masvekar, Ruturaj R., et al.
Publicado: (2022) -
Enhancing the clinical value of serum neurofilament light chain measurement
por: Kosa, Peter, et al.
Publicado: (2022) -
Neurofilament Light Chain Levels Correlate with Clinical Measures in
CLN3 Disease
por: Dang Do, An N., et al.
Publicado: (2020) -
Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
por: Masvekar, Ruturaj, et al.
Publicado: (2021) -
Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis
por: Masvekar, Ruturaj, et al.
Publicado: (2019)